[go: up one dir, main page]

WO2024220631A8 - Anti-allergenic ocular compositions - Google Patents

Anti-allergenic ocular compositions Download PDF

Info

Publication number
WO2024220631A8
WO2024220631A8 PCT/US2024/025142 US2024025142W WO2024220631A8 WO 2024220631 A8 WO2024220631 A8 WO 2024220631A8 US 2024025142 W US2024025142 W US 2024025142W WO 2024220631 A8 WO2024220631 A8 WO 2024220631A8
Authority
WO
WIPO (PCT)
Prior art keywords
allergenic
eyelid
ocular compositions
plant extract
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
PCT/US2024/025142
Other languages
French (fr)
Other versions
WO2024220631A1 (en
Inventor
Nat Adkins
Paramita SARKAR
Troy Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ocusoft Inc
Original Assignee
Ocusoft Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ocusoft Inc filed Critical Ocusoft Inc
Priority to CN202480026126.8A priority Critical patent/CN121001731A/en
Priority to KR1020257034288A priority patent/KR20250174610A/en
Priority to AU2024259079A priority patent/AU2024259079A1/en
Publication of WO2024220631A1 publication Critical patent/WO2024220631A1/en
Publication of WO2024220631A8 publication Critical patent/WO2024220631A8/en
Priority to MX2025012501A priority patent/MX2025012501A/en
Anticipated expiration legal-status Critical
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/133Amines having hydroxy groups, e.g. sphingosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/164Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/14Decongestants or antiallergics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/61Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/82Theaceae (Tea family), e.g. camellia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Detergent Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

An anti -allergenic product having: at least 0.01% w/w of a plant extract, wherein the plant extract is selected from the group consisting of Camellia sinensis leaf extract, Melaleuca alternifolia leaf oil, and mixtures thereof; an amphiphilic preservative, and a glycolipid. The eyelid cleansing composition is configured to relieve redness, discomfort and irritation in and around the eyelid.
PCT/US2024/025142 2023-04-20 2024-04-18 Anti-allergenic ocular compositions Pending WO2024220631A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CN202480026126.8A CN121001731A (en) 2023-04-20 2024-04-18 Antiallergic ocular composition
KR1020257034288A KR20250174610A (en) 2023-04-20 2024-04-18 Antiallergic ophthalmic composition
AU2024259079A AU2024259079A1 (en) 2023-04-20 2024-04-18 Anti-allergenic ocular compositions
MX2025012501A MX2025012501A (en) 2023-04-20 2025-10-20 ANTI-ALLERGENIC EYE COMPOSITIONS.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363497369P 2023-04-20 2023-04-20
US63/497,369 2023-04-20

Publications (2)

Publication Number Publication Date
WO2024220631A1 WO2024220631A1 (en) 2024-10-24
WO2024220631A8 true WO2024220631A8 (en) 2025-05-15

Family

ID=93153360

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2024/025142 Pending WO2024220631A1 (en) 2023-04-20 2024-04-18 Anti-allergenic ocular compositions

Country Status (7)

Country Link
KR (1) KR20250174610A (en)
CN (1) CN121001731A (en)
AR (1) AR132453A1 (en)
AU (1) AU2024259079A1 (en)
MX (1) MX2025012501A (en)
TW (1) TW202444403A (en)
WO (1) WO2024220631A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8281445B2 (en) * 2006-11-03 2012-10-09 Ocusoft, Inc. Heated eyelid cleanser
CA2883003C (en) * 2012-09-12 2021-11-16 Novaliq Gmbh Semifluorinated alkane compositions
CN108463212B (en) * 2015-11-09 2021-09-03 株式会社资生堂 Compositions and methods for application to skin
US20210212939A1 (en) * 2018-07-12 2021-07-15 Ocusoft, Inc. Anti-allergenic ocular compositions and eyelid cleansing wipes
CN114288234A (en) * 2022-02-11 2022-04-08 朱柳平 Repairing and skin-nourishing cosmetic and preparation method thereof

Also Published As

Publication number Publication date
TW202444403A (en) 2024-11-16
WO2024220631A1 (en) 2024-10-24
AR132453A1 (en) 2025-07-02
AU2024259079A1 (en) 2025-10-02
KR20250174610A (en) 2025-12-12
MX2025012501A (en) 2025-11-03
CN121001731A (en) 2025-11-21

Similar Documents

Publication Publication Date Title
KR20150017087A (en) Composition of hair cosmetic for prevention and improvement of dandruff and scalp pruritus comprising Manuka honey
WO2024220631A8 (en) Anti-allergenic ocular compositions
KR102373153B1 (en) Cosmetic composition having double layer and manufacturing method thereof
KR100879094B1 (en) Cosmetic composition for acne improvement containing a natural essential oil component and its hydrosol component
CN114306162A (en) Production and preparation process and application of plant extract for cosmetics
KR20200060168A (en) Care Pack after Brazilian Waxing and Manufacturing Method of it
KR20150100171A (en) Manufacturing method of cosmetic composition having shea butter and functional oil
JP6951592B2 (en) Compositions for the prevention or treatment of skin infections
CN107334677A (en) A kind of baby's moistening skin-care frost
CN105326680A (en) Hand sanitizer for children
KR20030052066A (en) Anti-dandruff hair-care cosmetic composition containing willow extract
KR20170033186A (en) Anti-atopic dermatitis antimicrobial wet tissue comprising eco-friendly antimicrobial agent
KR20090085845A (en) Shampoo Composition
CN110917078B (en) Natural plant shampoo
KR20120065034A (en) Composition for prevention and treatment of skin infection
KR100448434B1 (en) Hair-care cosmetic compositions having dandruff formation-suppressing effect
CN108030734B (en) Composition containing sweet wormwood herb and tea bran and application thereof
CN107375132B (en) A kind of aftershave lotion for firming, lightening, repairing, anti-inflammatory and thin, and preparation method thereof
KR20250074335A (en) A cosmetic composition for skin smoothing comprising natural extracts
KR20210043098A (en) Cosmetic composition for regulating microbe in skin comprising extract of rosa multiflora thunberg fruit or fractions from thereof
KR102587124B1 (en) Cosmetic composition for massage with improved moisturizing and rolling properties and gel containing the same
KR20200121365A (en) Composition containing extracts of citron seeds and brown rice
KR20250158386A (en) Feminine cleanser composition containing Chloranthus japonicus Siebold extract
CN107961201B (en) Skin-refreshing compound and application thereof
Agarwal et al. Awareness Of Medicinal Effects of Tamarindus Indica Among Dental Students.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 24793456

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: AU2024259079

Country of ref document: AU

Ref document number: 825303

Country of ref document: NZ

WWP Wipo information: published in national office

Ref document number: 825303

Country of ref document: NZ

ENP Entry into the national phase

Ref document number: 2024259079

Country of ref document: AU

Date of ref document: 20240418

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 1020257034288

Country of ref document: KR

Free format text: ST27 STATUS EVENT CODE: A-0-1-A10-A15-NAP-PA0105 (AS PROVIDED BY THE NATIONAL OFFICE)

WWE Wipo information: entry into national phase

Ref document number: KR1020257034288

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: CN2024800261268

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2501007105

Country of ref document: TH

WWE Wipo information: entry into national phase

Ref document number: 11202506269Y

Country of ref document: SG

WWP Wipo information: published in national office

Ref document number: 11202506269Y

Country of ref document: SG

WWE Wipo information: entry into national phase

Ref document number: 2024793456

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2024793456

Country of ref document: EP

Effective date: 20251120

ENP Entry into the national phase

Ref document number: 2024793456

Country of ref document: EP

Effective date: 20251120

ENP Entry into the national phase

Ref document number: 2024793456

Country of ref document: EP

Effective date: 20251120

ENP Entry into the national phase

Ref document number: 2024793456

Country of ref document: EP

Effective date: 20251120